Skip to content

Psilocybin for end-of-life distress: all studies

Page 2 of 4: studies 11 to 20 of 37, newest first. Back to the psilocybin for end-of-life distress overview

Research

Psilocybin and Death Anxiety: A Dual-Mechanism Approach to Existential Distress

August 1, 2025 Annabelle Swain

This literature review looks at how psilocybin, the active compound in "magic mushrooms," can help people deal with death anxiety; the deep fear of dying or losing control that shows up in lots of mental health struggles. While traditional treatments like SSRIs and talk therapy work for some people, they don't always get to the root of the problem. Psilocybin works differently. It changes brain...

Exploring psilocybin's role in mental health and palliative medicine: a path to improved well-being.

Expert Opinion on Emerging Drugs June 1, 2025 Maria-Alejandra Umbacia, Marta Ximena Leon, Jose-Manuel Quintero et al.

Although long known for their psychoactive effects, psychedelic drugs have only recently been investigated for medicinal use. Psilocybin has attracted the greatest interest with studies suggesting that it may be a useful agent in psychiatry and in palliative care. Clinical trials that included psilocybin were searched in PubMed, Embase, and ClinicalTrials.gov, demonstrating that adult...

Psilocybin as a Tool in the Management of Palliative Care: An Historical, Pharmacological and Clinical Approach

Medical & Clinical Case Reports Journal May 19, 2025 Andrés David Turizo Smith, Natalia Jaramillo, Diana Milena Berrío Cuartas

Psilocybin, a psychedelic compound in certain mushrooms, has been used for centuries in spiritual ceremonies and neuropsychiatric therapy.Despite its stigmatization as a Schedule I substance in 1970, research into psilocybin has resurged since the early 2000s, particularly in psychiatry and palliative care.This review examines psilocybins potential to improve the quality of life in palliative...

DOI: 10.51219/mccrj/andres-david-turizo-smith/233 (opens in new tab) Psilocybin Palliative care Intensive care medicine Hallucinogen +2

Evaluating the effectiveness of psilocybin in alleviating distress among cancer patients: A systematic review.

Palliative & Supportive Care April 22, 2025 Maria I Lapid, Sandeep R Pagali, Andrea L Randall et al. 9 citations

Psychological and existential distress is prevalent among patients with life-threatening cancer, significantly impacting their quality of life. Psilocybin-assisted therapy has shown promise in alleviating these symptoms. This systematic review aims to synthesize the evidence on the efficacy and safety of psilocybin in reducing cancer-related distress. We searched MEDLINE, APA PsycINFO, Cochrane...

Roadmap for Equitable Access and Responsible Use of Psilocybin-Assisted Psychotherapy in Palliative Care

Palliative Medicine Reports April 17, 2025 Michel Dorval, Sue-Ling Chang, Houman Farzin et al. 3 citations

Psilocybin-assisted psychotherapy represents a promising addition to palliative care interventions, potentially improving quality of life by addressing existential distress. Despite its safety and effectiveness, this therapy remains limited in Canada, underscoring the need for improved access to ease suffering from life-threatening illnesses. However, important questions remain regarding how to...

DOI: 10.1089/pmr.2024.0108 (opens in new tab) Psilocybin Palliative care Psychotherapist Hallucinogen

Therapeutic Potential of Psilocybin-Assisted Therapy in Hospice and Palliative Care

Revista Cacto - Ciência Arte Comunicação em Transdisciplinaridade Online April 3, 2025 Ana Cláudia Mesquita Garcia

Psilocybin-assisted therapy (PAT) has gained recognition as an innovative intervention in hospice and palliative care, demonstrating potential in mitigating the psychological, spiritual, and existential distress experienced by patients with serious illnesses. This article explores the role of PAT within these care settings, emphasizing its influence on various dimensions of human suffering, as...

DOI: 10.31416/cacto.v5i1.1448 (opens in new tab) Psilocybin Palliative care Hospice care Psychotherapist +2

A Modern Overview of the Potential Therapeutic Effects of Psilocybin in the Treatment of Depressive Disorders, Treatment-Resistant Depression, and End-of-Life Distress

Cureus March 17, 2025 Fejzic Dino 1 citation

The purpose of this review is to provide a comprehensive overview of the current findings and data on the therapeutic effects of psilocybin, a naturally occurring psychedelic alkaloid primarily found in Psilocybe mushrooms. This review covers psilocybin's efficacy and safety profile, therapeutic effects, proposed indications and contraindications, drug-drug interactions, adverse reactions,...

Set and setting in psilocybin-assisted therapy: A qualitative study of patients with cancer and depression.

General Hospital Psychiatry 2025 Yvan Beaussant, Elise C. Tarbi, Kabir Nigam et al. 3 citations

Psilocybin-assisted therapy (PAT) shows promise for cancer-related depression, yet little research has examined how therapeutic context shapes patient experiences. While set (mindset) and setting (environment) are considered central to psychedelic treatment, empirical evidence on their role in PAT acceptability remains limited. This study explores factors influencing the acceptability of PAT...

"Facing Death. . . Now, That's a Serious Thing to Confront" A Qualitative Analysis of Patient Perspectives on Psychedelic-Assisted Therapy for Cancer-Related Psychosocial Symptoms.

Integrative Cancer Therapies 2025 Haley D M Schuman, Sofia Barkova, Raèf Mina et al. 2 citations

People living with cancer (PLWC) often face profound existential distress that is insufficiently addressed by conventional psychosocial supports. This qualitative study explored PLWC's attitudes, beliefs, and experiences regarding psychedelic-assisted therapy (PAT) as a novel approach to addressing psychosocial suffering, particularly existential distress. Fifteen participants with varying...

Psychedelics for the treatment of end-of-life distress in patients with a life-threatening disease.

International review of neurobiology 2025 Stephan Tap, Tijmen Bostoen, Joost J. Breeksema et al. 4 citations

Patients with a life-threatening disease (LTD) sometimes suffer from end-of-life distress (EOLD) which refers to the physical, psychological, emotional, and spiritual suffering related to chronic illness and the possibility of death. Palliative care interventions seek to improve the quality of life of patients with EOLD and their significant others. Currently, a range of psychological and...